Exagen

$Exagen(XGN)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001140361-26-004799  Act: 34  Size: 10 KB 网页链接

$Exagen(XGN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001274737-26-000009  Act: 34  Size: 12 MB 网页链接

$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001843113-26-000002  Size: 5 KB 网页链接

$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001449439-26-000003  Size: 4 KB 网页链接

$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001449439-26-000005  Size: 9 KB 网页链接

$Exagen(XGN)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001274737-26-000003  Act: 34  Size: 175 KB 网页链接

$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001843113-26-000004  Size: 7 KB 网页链接

$Exagen(XGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001274737-26-000007  Act: 34  Size: 371 KB 网页链接

$Exagen(XGN)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001493215-26-000034  Act: 34  Size: 13 KB 网页链接

$Exagen(XGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001843113-26-000006  Size: 8 KB 网页链接

$Exagen(XGN)$ Jorey Chernett 已提交了13G表格，报告其持有Exagen Inc.普通股1,231,438股，占该类别股份的5.43%。这一所有权于2026年1月30日确立。Chernett证明这些股份并非为影响Exagen Inc.的控制权而收购或持有。该文件于2026年2月4日提交。Exagen Inc.的主要执行办公室位于加利福尼亚州维斯塔...

$Exagen(XGN)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0002042077-26-000013  Act: 34  Size: 6 KB 网页链接

$Exagen(XGN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001274737-26-000011  Size: 3 KB 网页链接